Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review [0.03%]
转移性激素敏感性前列腺癌局部治疗的证据和新趋势：综述
Stephan Brönimann,Nirmish Singla,Stephan M Korn et al.
Stephan Brönimann et al.
Introduction: Metastatic hormone-sensitive prostate cancer (mHSPC) displays both simultaneous and sequential patterns of metastasis, emphasizing a comprehensive treatment approach that integrates both local therapy and sy...
Best of hematology-2021 [0.03%]
2021年血液学亮点回顾
Katharina Theresa Prochazka
Katharina Theresa Prochazka
Editorial
Memo. 2023;16(1):36-37. DOI:10.1007/s12254-022-00826-5 2023
Austrian Society for Hematology and Medical Oncology (OeGHO) spring meeting 2023 [0.03%]
2023年奥地利血液学与医学肿瘤学学会(OeGHO)春季会议
Ewald Wöll
Ewald Wöll
Editorial
Memo. 2023;16(1):3. DOI:10.1007/s12254-022-00865-y 2023
Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review [0.03%]
癌症成人患者的SARS-CoV-2疫苗接种：简短回顾
Waltraud Elisabeth Huf,Arschang Valipour
Waltraud Elisabeth Huf
Compared to individuals without cancer, patients with a diagnosis of malignancy bear a higher risk of becoming infected with SARS-CoV‑2, suffer more frequently from disease-related complications, and are more likely to die due to coronavir...
Andreas Petzer
Andreas Petzer
Editorial
Memo. 2022;15(4):255-256. DOI:10.1007/s12254-022-00851-4 2022
Clemens A Schmitt
Clemens A Schmitt
Editorial
Memo. 2022;15(2):100-101. DOI:10.1007/s12254-022-00813-w 2022
COVID-19 crisis and cancer [0.03%]
新冠肺炎疫情与癌症
Rupert Bartsch,Wolfgang Hilbe
Rupert Bartsch
Editorial
Memo. 2022;15(2):98-99. DOI:10.1007/s12254-022-00812-x 2022
Tracking mutation and drug-driven alterations of oncokinase conformations [0.03%]
追踪肿瘤蛋白激酶结构的变异和药物诱导的变化
Andreas Feichtner,Valentina Kugler,Selina Schwaighofer et al.
Andreas Feichtner et al.
Numerous kinases act as central nodes of cellular signaling networks. As such, many of these enzymes function as molecular switches for coordinating spatiotemporal signal transmission. Typically, it is the compartmentalized phosphorylation ...
Christoph Suppan
Christoph Suppan
The congress of the European Society of Medical Oncology (ESMO) that recently took place virtually was marked by highlights in many different cancer types. New therapeutic options especially in metastatic breast cancer will hopefully bring ...
Lukas Weiss
Lukas Weiss
This short review reflects on a personal selection of three abstracts on colorectal cancer (CRC) presented at the 2021 ESMO Congress: (1) KRASG12C as a new therapeutic target in metastatic CRC, supported by data from the KRYSTAL‑1 and Code...